This inventor holds 2 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1997-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1999
Title: Gary K. Darland: Innovator in Antiprotozoal Research
Introduction
Gary K. Darland is a notable inventor based in Mountainside, NJ (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of antiprotozoal agents. With a total of 2 patents, his work focuses on innovative solutions for treating protozoal diseases.
Latest Patents
Darland's latest patents include groundbreaking cyclic tetrapeptides that are useful in the treatment or prevention of protozoal diseases. These novel compounds are specifically active against the causative pathogens in malaria, toxoplasmosis, and coccidiosis. His research aims to provide effective therapeutic options for these serious health concerns.
Career Highlights
Gary K. Darland is associated with Merck & Company, Inc., a leading global healthcare company. His role at Merck has allowed him to collaborate with other talented professionals in the field. His dedication to research and innovation has positioned him as a key figure in the development of new treatments.
Collaborations
Some of his notable coworkers include Christine Lange Cannova and Michael A. Goetz. Their collaborative efforts contribute to the advancement of research in antiprotozoal therapies.
Conclusion
In summary, Gary K. Darland is a distinguished inventor whose work in antiprotozoal cyclic tetrapeptides has the potential to impact the treatment of protozoal diseases significantly. His contributions to the field exemplify the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile